Geneplus
Latest round
- Series D
Last raised
- Nov 2025
Total raised
- $254M
Investors
- 28
About Geneplus
, trading as Geneplus operates as a cancer prevention testing service company. The company was co-founded by CEO Dr. Yi Xin and President Dr. Yang Ling. The company has more than 700 employees and an operating area of more than 13,000 square meters. The company operates as a cancer prevention testing service provider that develops clinical services and products for customers, such as precise drug use, curative effect monitoring, postoperative recurrence detection, and screening. Geneplus is engaged in clinical detection, medical equipment production, technology cooperation, and services, as well as the treatment and prevention of tumors. The company generates revenue by doing research, development and sales of its products and other related services.
Who invested in Geneplus
28 investors across 6 rounds
See all investors in Geneplus
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Geneplus
Who invested in Geneplus?
Geneplus has 28 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Geneplus raised?
Geneplus has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Geneplus last raise money?
Geneplus's most recent round on record is a Series D, in Nov 2025.
What does Geneplus do?
, trading as Geneplus operates as a cancer prevention testing service company.
Where is Geneplus headquartered?
Geneplus is headquartered in Beijing, China.
Which VCs invest in companies like Geneplus?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Geneplus's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Geneplus? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.